News

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...
Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an ...
Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.
Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...
The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.